Old Web
English
Sign In
Acemap
>
authorDetail
>
Debasish Roychowdhury
Debasish Roychowdhury
Princeton University
ROS1
non-small cell lung cancer (NSCLC)
Clinical endpoint
Phases of clinical research
Anaplastic lymphoma kinase
2
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II study of crizotinib in east Asian patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC).
2016
Journal of Clinical Oncology
Koichi Goto
James Chih-Hsin Yang
Dong-Wan Kim
Shun Lu
Takashi Seto
Jin-Ji Yang
Noboru Yamamoto
Myung-Ju Ahn
Toshiaki Takahashi
Takeharu Yamanaka
Allison Kemner
Debasish Roychowdhury
Jolanda Paolini
Keith D. Wilner
Yi-Long Wu
Show All
Source
Cite
Save
Citations (12)
Phase II study of crizotinib in east Asian patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC).
2016
Journal of Clinical Oncology
Koichi Goto
James Chih-Hsin Yang
Dong-Wan Kim
Shun Lu
Takashi Seto
Jin-Ji Yang
Noboru Yamamoto
Myung-Ju Ahn
Toshiaki Takahashi
Takeharu Yamanaka
Allison Kemner
Debasish Roychowdhury
Jolanda Paolini
Keith D. Wilner
Yi-Long Wu
Show All
Source
Cite
Save
Citations (13)
1